You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HBV

Showing 1 - 25 of 1,845
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Optimizing HBV Care Cascade Among Foreign-Born in United States

Recruiting
  • Chronic Hepatitis B Virus (Hbv)
    • Los Angeles, California
    • +1 more
    Feb 2, 2023

    Cutaneous Warts Trial (Hepatitis B Virus Vaccine(HBV))

    Not yet recruiting
    • Cutaneous Warts
    • Hepatitis B Virus Vaccine(HBV)
    • (no location specified)
    Jun 13, 2023

    Dynamic Changes of Serum HBV RNA in Chronic Hepatitis B Patients

    Not yet recruiting
    • Chronic Hepatitis B Patients
      • Beijing, Beijing, China
        Beijing Friendship Hospital, Capital Medical University
      Aug 15, 2023

      Hepatitis B Reactivation, Hematopoietic Stem Cell Transplantation, Antiviral Drug Trial in Seoul (Entecavir)

      Enrolling by invitation
      • Hepatitis B Reactivation
      • +3 more
      • Seoul, Korea, Republic of
        Jeong Won Jang
      Dec 16, 2022

      Single-cell RNA Sequencing Resolves Regulatory Role of HBV on

      Recruiting
      • HBV
      • Primary Liver Cancer
      • HBV DNA Sequencing
      • Wuhan, Hubei, China
        Zhongnan Hospital of Wuhan University
      Dec 22, 2022

      Study of Serum Tumor Markers of HBV Associated HCC

      Not yet recruiting
      • HCC
      • tumor tissue and blood tests
      • (no location specified)
      Apr 10, 2023

      Chronic Hepatitis b Trial in Lyon (procedure, biological, other)

      Not yet recruiting
      • Chronic Hepatitis b
      • Investigation of the intrahepatic compartment using the fine needle aspiration (FNA) technique
      • +2 more
      • Lyon, France
        Hepatology Department - Hospices Civils de Lyon
      Sep 14, 2023

      Hepatocellular Carcinoma Trial in Singapore (mRNA HBV/TCR T-cells)

      Recruiting
      • Hepatocellular Carcinoma
      • mRNA HBV/TCR T-cells
      • Singapore, Singapore
        Singapore General Hospital
      Jun 27, 2022

      HBV Reactivation in Anti CD20 Treatment

      Active, not recruiting
      • Hepatitis B
        • Afula, Tsafon, Israel
          HaEmek Medical Center
        Mar 14, 2023

        Gut Microbiome in People Living With HIV and HBV

        Not yet recruiting
        • Human Immunodeficiency Virus
        • +2 more
          • (no location specified)
          Nov 8, 2023

          Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients

          Recruiting
          • AIDS
          • Hepatitis B
          • Peginterferon alfa-2b Injection
          • Guangzhou, Guangdong, China
            Guangzhou Eighth People's Hospital, Guangzhou Medical University
          Aug 10, 2023

          Chronic Hepatitis b, Tenofovir Alafenamide Fumarate Trial in Hangzhou (Tenofovir Alafenamide Tablets)

          Recruiting
          • Chronic Hepatitis b
          • Tenofovir Alafenamide Fumarate
          • Tenofovir Alafenamide Tablets
          • Hangzhou, Zhejiang, China
            Hangzhou First People's Hospital
          May 8, 2023

          Chronic Hepatitis B Trial in Hong Kong, Auckland (VRON-0200-AdC6, VRON-0200-AdC7)

          Recruiting
          • Chronic Hepatitis B
          • VRON-0200-AdC6
          • VRON-0200-AdC7
          • Hong Kong, Hong Kong
          • +1 more
          Oct 6, 2023

          Hiv, Syphilis, HBV Trial (TRI-MOM intervention)

          Not yet recruiting
          • Hiv
          • +2 more
          • TRI-MOM intervention
          • (no location specified)
          Jul 10, 2023

          Malnutrition, Hepatitis B,Chronic, Acute-On-Chronic Liver Failure Trial in Guangzhou (Individual nutritional support)

          Recruiting
          • Malnutrition
          • +3 more
          • Individual nutritional support
          • Guangzhou, Guangdong, China
            Third Affiliated Hospital of Sun Yat-sen University
          Nov 9, 2023

          Vaccine-Preventable Diseases, Hepatitis B Trial in Seongnam-si (CVI-HBV-002)

          Completed
          • Vaccine-Preventable Diseases
          • Hepatitis B
          • CVI-HBV-002
          • Seongnam-si, Gyeonggi-do, Korea, Republic of
            CHA University Bundang Medical Center
          Nov 19, 2023

          Hepatocellular Carcinoma, Hepatitis b Virus, Radiotherapy Trial

          Not yet recruiting
          • Hepatocellular Carcinoma
          • +3 more
            • (no location specified)
            Feb 21, 2023

            HBV Trial in Wuhan (hUCMSCs)

            Recruiting
            • HBV
            • hUCMSCs
            • Wuhan, Hubei, China
              Zhongnan Hospital of Wuhan University
            Jun 27, 2022

            Diphtheria Trial in Schoenau Am Koenigssee, Milano, Santiago de Compostela (DTPa-HBV-IPV/Hib, DTaP5-HBV-IPV-Hib, Pneumococcal

            Completed
            • Diphtheria
            • DTPa-HBV-IPV/Hib
            • +2 more
            • Rosenheim, Bayern, Germany
            • +19 more
            Jan 24, 2023

            NSCLC Stage IV, HIV, HBV Trial in Verona (Nivolumab and Ipilimumab)

            Not yet recruiting
            • NSCLC Stage IV
            • +4 more
            • Nivolumab and Ipilimumab
            • Verona, Veneto/Verona, Italy
              Centro Ricerche Cliniche
            Oct 26, 2022

            Chronic Hepatitis B Trial in Beijing (TCR-T)

            Active, not recruiting
            • Chronic Hepatitis B
            • TCR-T
            • Beijing, China
              The Fifth Medical Center of PLA General Hospital
            Jun 13, 2023

            Liver Cancer, Hepatocellular Carcinoma Trial in Chengdu (HBV mRNA vaccine)

            Recruiting
            • Liver Cancer
            • Hepatocellular Carcinoma
            • HBV mRNA vaccine
            • Chengdu, Sichuan, China
              West China Hospital, Sichuan University
            Feb 12, 2023

            Towards a Functional Cure for HBV - The COMMIT Cohort Study

            Active, not recruiting
            • Hiv
            • HBV Coinfection
              • Chennai, India
              • +2 more
              May 30, 2022

              DELTA DESCRIBE: THE FRENCH COLLABORATIVE PROJECT

              Recruiting
              • Hepatitis D
              • Patients co-infected HBV/HDV
              • Limoges, France
                Chu Limoges
              Jun 27, 2023

              Hepatocellular Carcinoma Trial in Beijing, Shanghai, Shenyang (SCG101, PD1/PD-L1 checkpoint inhibitor)

              Recruiting
              • Hepatocellular Carcinoma
              • SCG101
              • PD1/PD-L1 checkpoint inhibitor
              • Beijing, China
              • +3 more
              May 7, 2022